Abstract
There have been notable improvements in the treatment of oral cancers. The objective of this study was to see whether these improvements have translated into survival benefits at the population level from the SEER database. This is a retrospective study using the SEER 19 Custom database which included patients diagnosed with oral cancer between January 1, 1995, and December 31, 2015. The overall stage, age, sex, and treatment modalities were the covariates. For analysis, the patients were divided into four cohorts as per their year of diagnosis—cohort I included patients who were diagnosed between 1995 and 2000 (n = 3873), cohort II between 2001 and 2005 (n = 5881), cohort III between 2006 and 2010 (n = 6233), and cohort IV between 2011 and 2015 (n = 12567). Patients undergoing surgery with adjuvant therapy have increased significantly across cohorts and there is a significant fall in patients undergoing non-surgical treatment. Pairwise comparison by the Mantel-Cox test showed that cohort IV had significantly improved median overall survival (OS) and disease-specific survival (DSS) as compared to other cohorts and there was a significant impact of treatment modality on OS and DSS, especially in cohorts III and IV (p<0.001). Though geographical variations in the presentation and habits limit the generalization of these results, this study demonstrates that the changes and improvements in treatment paradigms incorporating level I evidence and surgical techniques have translated into improved survival outcomes at the population level. We recommend further studies on the local population to lend further credence to our observation.
Similar content being viewed by others
References
Tota JE, Anderson WF, Coffey C, Califano J, Cozen W, Ferris RL et al (2017) Rising incidence of oral tongue cancer among white men and women in the United States, 1973-2012. Oral Oncol 67:146–152
Patel SC, Carpenter WR, Tyree S, Couch ME, Weissler M, Hackman T et al (2011) Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol 29(11):1488–1494
Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsagué X, Laporte L et al (2014) HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol 15(12):1319–1331
Liang X-H, Lewis J, Foote R, Smith D, Kademani D (2008) Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience. J Oral Maxillofac Surg 66(9):1875–1880
Iyer NG, Tan DSW, Tan VKM, Wang W, Hwang J, Tan N-C et al (2015) Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis. Cancer 121(10):1599–1607
Robertson AG, Soutar DS, Paul J, Webster M, Leonard AG, Moore KP et al (1998) Early closure of a randomized trial: surgery and postoperative radiotherapy versus radiotherapy in the management of intra-oral tumours. Clin Oncol (R Coll Radiol) 10(3):155–160
Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350(19):1937–1944
Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre J-L, Greiner RH et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350(19):1945–1952
Peters LJ, Goepfert H, Ang KK, Byers RM, Maor MH, Guillamondegui O et al (1993) Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 26(1):3–11
Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A et al (2005) Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27:843–850
Huang T-Y, Hsu L-P, Wen Y-H, Huang T-T, Chou Y-F, Lee C-F et al (2010) Predictors of locoregional recurrence in early stage oral cavity cancer with free surgical margins. Oral Oncol 46(1):49–55
Liao C-T, Chang JT-C, Wang H-M, Ng S-H, Hsueh C, Lee L-Y et al (2008) Does adjuvant radiation therapy improve outcomes in pT1-3N0 oral cavity cancer with tumour-free margins and perineural invasion? Int J Radiat Oncol Biol Phys 71(2):371–376
Bur AM, Lin A, Weinstein GS (2016) Adjuvant radiotherapy for early head and neck squamous cell carcinoma with perineural invasion: a systematic review. Head Neck 38(Suppl 1):E2350–E2357
Huang SH, Hwang D, Lockwood G, Goldstein DP, O'Sullivan B (2009) Predictive value of tumour thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a meta-analysis of reported studies [Internet]. Cancer Interdiscip Int J American Cancer Soc 115(7):1489–1497
Ebrahimi A, Gil Z, Amit M, Yen T-C, Liao C-T, Chaturvedi P et al (2019) Depth of invasion alone as an indication for postoperative radiotherapy in small oral squamous cell carcinomas: an International Collaborative Study. Head Neck 41(6):1935–1942
Trifiletti DM, Smith A, Mitra N, Grover S, Lukens JN, Cohen RB et al (2017) Beyond positive margins and extracapsular extension: evaluating the utilization and clinical impact of postoperative chemoradiotherapy in resected locally advanced head and neck cancer. J Clin Oncol 35(14):1550–1560
Surveillance, Epidemiology and End Results (SEER) Programwww.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Data, 9 Registries, Nov 2020 Sub (1975-2018) - Linked To County Attributes - Time-Dependent (1990-2018) Income/Rurality, 1969-2019 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2021, based on the November 2020 submission
Acknowledgements
Dr. Atanu Bhattacharjee, Statistician.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Approval
All the details necessary for analysis were collected from the SEER database. The data was accessed after an agreement with SEER regarding its usage [17]. There is no direct contact between the researcher and participants. All details regarding the patients are kept confidential. No details which can be used to identify the patient are published.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ramalingam, N., Chidambaranathan, N., Thiagarajan, S. et al. Impact of Changes in Treatment Paradigms on Survival in Oral Squamous Carcinoma—a Population-Level Study. Indian J Surg Oncol 14, 843–849 (2023). https://doi.org/10.1007/s13193-023-01790-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-023-01790-0